Your search returned 9 studies. (Get alerts for new studies):
- Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.
Conditions: Basal Cell Carcinoma - Melanoma - Squamous Cell Carcinoma - Non-Malignant Skin Disorders
1 Location available
- Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders
Conditions: Non Malignant Disorders - Immunodeficiencies - Congenital Marrow Failures - Hemoglobinopathies - Inborn Errors of Metabolism - Sickle Cell - Thalassemia - Lysosomal Storage Disease
1 Location available
- Fludarabine, Melphalan, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Dis
Conditions: Chronic Myeloproliferative Disorders - Fanconi Anemia - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Paroxysmal Nocturnal Hemoglobinuria
1 Location available
- Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Conditions: Nonmalignant Neoplasm
4 Locations available
- Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs
Conditions: Sickle Cell Disease - Thalassemia - Diamond-Blackfan Anemia
2 Locations available
- Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders
Conditions: Non Malignant Diseases - Immunodeficiencies - Hemoglobinopathies
1 Location available
- Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Nonmalignant Neoplasm
1 Location available
- Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol S
1 Location available
- Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Conditions: Metabolic Disorders - Hematologic, Immune, or Bone Marrow Disorders - Hemoglobinopathies
15 Locations available
|